Zevra Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:ZVRA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 18.14 M16.25 M8.22 M3.6 M-4.71 M 23.36 M Cash from investing activities 2.03 M5.47 M10.54 M11.93 M-4.58 M 23.37 M Cash from financing activities 64.77 M796 K1.61 M1.38 M6.53 M 10.31 M Free cash flow 18.14 M16.25 M8.12 M3.39 M-5.26 M 22.5 M

News

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates

CEO von Zevra Therapeutics verkauft Aktien im Wert von 125.000 $

Neil F. McFarlane, Zevra Therapeutics president, sells $125k in shares

Zevra Therapeutics: CMO Quartel veräußert Aktien im Wert von 40.000 US-Dollar/n

Zevra Therapeutics: CCO Schafer veräußert Aktienpaket im Wert von 29.800 US-Dollar

Zevra Therapeutics CMO Quartel sells $40k in shares

Schafer Joshua, CCO of Zevra, sells $29,800 in ZVRA stock

CEO von Zevra Therapeutics veräußert Aktien im Wert von 853.000 $

Zevra Therapeutics CEO McFarlane sells $853k in shares

Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Zevra Stock: Asymmetric Risk-Reward Setup In Ultra-Rare Disease Market (ZVRA)